In HCV‐related HCC patients, overactivation of STAT3 is closely linked to tumor progression and poor prognosis, underscoring the pivotal role of JAK–STAT pathway in HCV‐induced HCC [415]. Here, STAT3 is linked to hepatocellular carcinoma.